Regional gene repression by DNA double-strand breaks in G1 phase cells by Purman, Caitlin E et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
2019 
Regional gene repression by DNA double-strand breaks in G1 
phase cells 
Caitlin E. Purman 
Patrick L. Collins 
Sofia I. Porter 
Ankita Saini 
Harshath Gupta 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Caitlin E. Purman, Patrick L. Collins, Sofia I. Porter, Ankita Saini, Harshath Gupta, Barry P. Sleckman, and 
Eugene M. Oltz 
Regional Gene Repression by DNA Double-Strand Breaks in G1
Phase Cells
Caitlin E. Purman,a,b Patrick L. Collins,a,d Soﬁa I. Porter,a,d Ankita Saini,a,d Harshath Gupta,a Barry P. Sleckman,c
Eugene M. Oltza,d
aDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
bMolecular Genetic and Genomics Graduate Program, Washington University School of Medicine, St. Louis, Missouri, USA
cDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA
dDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA
ABSTRACT DNA damage responses (DDR) to double-strand breaks (DSBs) alter cel-
lular transcription programs at the genome-wide level. Through processes that are
less well understood, DSBs also alter transcriptional responses locally, which may be
important for efﬁcient DSB repair. Here, we developed an approach to elucidate the
cis-acting responses to DSBs in G1 phase cells. We found that DSBs within a gene
body silence its expression, as well as the transcription of local undamaged genes at
a distance deﬁned by the spread of -H2AX from the DSB. Importantly, DSBs not
only repress ongoing transcription but also block the inducible expression of regional
genes. DSB-mediated transcriptional repression depends on DDR signaling but does
not require the generation of inaccessible chromatin. Our ﬁndings demonstrate that
in G1 phase cells, DDR signaling establishes a robust and extensive region of tran-
scriptional repression spreading from DSB sites and introduce an approach to study
the mechanistic impact of targeted DNA breaks in nearly any chromatin environ-
ment.
KEYWORDS DNA damage, DNA damage signaling, chromatin, nonhomologous DNA
end joining, transcriptional regulation
DNA double-strand breaks (DSBs) are dangerous genomic lesions that derive froma variety of sources, including exogenous agents (e.g., ionizing radiation), basic
cellular processes (e.g., transcription and DNA replication), or developmental programs
(e.g., antigen receptor gene rearrangement) (1–3). The consequences of aberrant DSB
repair range from apoptosis to mutations that fuel carcinogenesis. To protect against
these adverse outcomes, eukaryotic cells have developed two major pathways for DSB
repair: nonhomologous end joining (NHEJ) and homologous recombination (HR). NHEJ
occurs throughout the cell cycle and involves the direct ligation of broken DNA ends,
whereas HR, which uses the sister chromatid as a template for repair, is restricted
primarily to the S and G2 phases (4, 5). Given that most mammalian somatic cells reside
in G0/G1, NHEJ represents the major pathway for DSB repair and genome maintenance.
However, NHEJ-mediated repair also can lead to chromosomal rearrangements, espe-
cially in the context of complex DSB end structures or chromatin environments in which
breaks are not resolved quickly (6–8). As such, a critical goal is to understand the
interplay between the genetic, epigenetic, and structural features of a chromosomal
break site, as well as the downstream functional outcomes in G0/G1 phase cells.
DSBs initiate a canonical DNA damage response (DDR) that regulates not only their
repair but also other cellular processes, including cell cycle arrest, transcriptional
programs, and chromatin reorganization (3, 9–11). In G0/G1 phases, DSBs are sensed by
the Mre11/Rad50/Nbs1 (MRN) complex and the Ku70/80 heterodimer, which activate
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the phosphatidylinositol 3-kinase-like protein kinase (PI3KK) family members ATM and
DNA-PKcs. These kinases phosphorylate hundreds of downstream effector molecules
that function in the canonical DDR (12–14). A key target of ATM and DNA-PKcs is the
histone variant H2AX, which is phosphorylated on serine 139, forming -H2AX. This
histone posttranslational modiﬁcation can propagate from the break site, extending for
megabases along chromatin to form -H2AX domains (15). The -H2AX domains act as
scaffolds for recruitment and retention of other nuclear factors involved in histone
modiﬁcation, chromatin remodeling, end processing, and repair (16, 17). Thus, DSBs
initiate a signaling cascade that drives substantial alterations in the genomic microen-
vironment, including the regional landscape of chromatin and nuclear factors. To this
end, the downstream functional consequences of DSB signaling on local, regional, and
global gene expression in G0/G1 phase cells remain largely unexplored.
In cycling cells, DSBs at or near an active gene transiently repress its transcription via
ATM- and DNA-PKcs-dependent mechanisms (18–22). However, DSBs activate diver-
gent signaling pathways, depending on the cell cycle phase in which they occur,
leading to vastly different cellular responses. For example, DDR signaling activates
distinct checkpoint and repair pathways in G1 versus S versus G2 phases, each of which
recruits its own sets of factors to DSB-proximal chromatin (23, 24). As such, the speciﬁc
cell cycle phase in which a DSB occurs may differentially impact local chromatin reorgani-
zation, DSB end processing, and, likely, the transcription of genes near a lesion. With
regard to the transcription of genes near a lesion, a persistence of transcription near a
break site could cooperate or interfere with repair processes, especially given that NHEJ
factors form complexes with RNA polymerase II (RNAPII) when DSBs occur in tran-
scribed genes (25). RNA-DNA hybrids also accumulate at endogenous DSBs in transcrip-
tionally active regions, where they may inﬂuence NHEJ and HR (26, 27). Conversely, RNA
polymerase complexes and RNA-DNA hybrid structures at the DSB site could act as
physical barriers to end processing and repair (28, 29). Thus, controlling transcriptional
activity in the vicinity of a DSB may be a critical component of the mechanisms that
facilitate the rapid and precise resolution of the lesion (29, 30).
We developed an approach to study DDR regulation of transcription at loci harbor-
ing a single, targeted DSB in G0/G1 phase cells. We chose a cell system in which DSBs
persist unrepaired, which generates a sustained DNA damage response and which
allows us to detect changes that may otherwise be obscured by rapid repair. We found
that DSBs targeted to sites either within or several kilobases outside of a gene body
repress its ongoing transcription. Importantly, the same lesions also block induced
expression of the proximal gene, indicating that ongoing transcription is not required
for DSB-mediated repression. Remarkably, we found that transcriptional repression
spreads to distal genes within the -H2AX domain in a DDR-dependent manner. Together,
our ﬁndings provide a rigorous demonstration that genomic DSBs incurred in G0/G1
suppress regional gene expression and underscore the utility of our experimental
model for a systematic dissection of the responses to DSBs within a range of chromatin
environments.
RESULTS
Generation of persistent, targeted DSBs in G1 phase cells. To interrogate the local
transcriptional response to DSBs, we developed an experimental system to generate
high levels of persistent DSBs at predetermined sites in the genome of G1-synchronized
cells (Fig. 1A). Speciﬁcally, we employed a v-Abl-transformed murine pre-B cell line
(Abelson line) that can be arrested in G1 phase by treatment with the Abl kinase
inhibitor imatinib (STI571 or STI) (31). We chose a cell line that was deﬁcient for the core
NHEJ factor, DNA ligase IV. Because NHEJ is the major DSB repair pathway utilized in
noncycling cells, DSBs persist unrepaired in these Abelson lines when they are placed
under G1 arrest (32).
To target DSBs at preselected genomic sites, a doxycycline-inducible Cas9 (pCW-
Cas9) was stably integrated into Abelson cells deﬁcient for DNA ligase IV (LigIV/:iCas9
cells). Treatment of cycling LigIV/:iCas9 cells with doxycycline induced robust Cas9
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protein expression, which persisted after G1 arrest (Fig. 1B). Sequences corresponding
to several genomic sites were cloned into a modiﬁed pKLV-gRNA plasmid that con-
tained a guide RNA (gRNA) expression cassette and that harbored the Thy1.1 cell
surface marker. Nucleofection of the gRNA plasmid into G1-arrested LigIV/:iCas9 cells
resulted in 90% Thy1.1 positivity (Fig. 1C). G1-arrested cells treated with doxycycline
and transfected using nucleofection (nucleofected) with a gRNA expression vector
designed to target the endogenous enhancer of Tcrb (gEb) accumulated breaks at the
Eb target site (Fig. 1D). To ensure that Cas9-generated DSBs elicit a canonical DNA
damage response (DDR) in our system, we mapped -H2AX formation in cells nucleo-
fected with gEb or no gRNA as a control. Consistent with the ﬁndings of prior studies,
the -H2AX modiﬁcation extended for several hundred kilobases on either side of the
break site in cells nucleofected with gEb (Fig. 1E). No -H2AX domain was observed in
the control cells or at other loci in gEb-expressing cells (Fig. 1E; data not shown). These
FIG 1 Generation of persistent, targeted breaks in G1 phase cells using CRISPR/Cas9. (A) Work ﬂow for CRISPR/
Cas9-induced breaks in LigIV/:iCas9 v-Abl-transformed pre-B cells. (B) Intracellular staining and ﬂow cytometric
analysis for FLAG-Cas9 in cycling (top) and G1-arrested (bottom) LigIV/:iCas9 cells that were untreated or treated
with doxycycline for the indicated times. (C) Staining for the Thy1.1 cell surface marker and ﬂow cytometric analysis
for Thy1.1 in G1-arrested LigIV/:iCas9 cells nucleofected with the pKLV-U6gRNA(BbsI)-UbcThy1.1 gRNA expression
vector and nonnucleofected cells. (D) (Top) Schematic of the Southern blotting strategy to detect cleaved alleles
at the enhancer of Tcrb (Eb). (Bottom) Southern blot showing intact and cut Eb alleles at 0 and 24 h after
nucleofection of LigIV/:iCas9 cells with a gRNA plasmid targeting Eb (gEb). (E) UCSC Genome Browser screenshot
depicting the -H2AX ChIP-seq signal at the Eb locus in G1-arrested, LigIV/:iCas9 cells at 24 h after nucleofection
with gEb (bottom track) or no gRNA (top track). The arrow indicates the gEb target site. Dox and dox, doxycycline;
SSC, side scatter; FSC, forward scatter.
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data indicate that DDR signaling is intact in these G1-arrested cells and is speciﬁc to
regions targeted for a DSB.
Persistent DSBs in G1 phase repress transcription of an active endogenous
gene. We ﬁrst set out to determine how persistent DSBs within an active endogenous
gene affect its transcription. We chose to target the Irf4 locus, which is constitutively
expressed in our cell line. G1-arrested, LigIV/:iCas9 cells were nucleofected with a
gRNA targeting a site within Irf4 intron 6, about 6.3 kb downstream of the Irf4 promoter
(Fig. 2A). As expected, we observed high levels of persistent DSBs at the target site at
24 h postnucleofection (Fig. 2B). A persistent break within the Irf4 gene body signiﬁ-
cantly reduced the levels of its corresponding mRNA, as measured by reverse tran-
scription (RT)-quantitative PCR (qPCR) analysis at 24 h postnucleofection (Fig. 2C). In
contrast, expression of a control gene, Tnks2, located on a different chromosome, was
unaffected (Fig. 2C). Analysis of nascent transcript levels yielded comparable results
(Fig. 2D). Similar reductions in transcript levels were observed using primers for regions
upstream (primer set P1) or downstream (primer set P2) of the DSB site. Because the
break interrupts the transcriptional unit, the observed effects on transcription could be
due to active repression, the instability of truncated transcripts, or both. To determine
whether DSB repression of transcription requires the disruption of the gene body, we
targeted Cas9 to a site 9.5 kb upstream of the Irf4 promoter (Fig. 2A and E). As observed
for breaks within the gene body, a DSB upstream of the same transcriptional unit led
to a nearly identical reduction in total and nascent transcripts (Fig. 2F and G). We
conclude that single DSBs in G1 phase can silence expression of proximal genes, even
when they do not directly interrupt the transcriptional unit.
DSBs block transcriptional activation of an inducible endogenous gene. To
understand whether DSBs can regulate the induction of gene expression, we targeted
Cas9 to the endogenous Iﬁt locus, which harbors a cluster of interferon-inducible genes.
Importantly, regulation of these genes is restricted to the activities of their proximal
promoters, which harbor multiple interferon-stimulated response elements (ISREs) that
bind the STAT1/2 transcription factors (33, 34). Indeed, expression of Iﬁt1 is rapidly
induced in G1-arrested, LigIV/ Abelson cells upon treatment with the type I inter-
feron, interferon beta (IFN-) (Fig. 3A), without inducing a DNA damage response (Fig.
3B). Thus, the Iﬁt1 locus provides an excellent model to test if DSBs not only silence
ongoing gene transcription but also block the activation of transcription at genes
proximal to the lesion.
We targeted Cas9 to two sites at the Iﬁt1 locus, one 3 kb downstream of Iﬁt1 (gIﬁt1
3=) and one within the Iﬁt1 gene body (gIﬁt1 intron) (Fig. 3C to E). The former DSB lies
12 kb 3= of the Iﬁt1 promoter, while the latter is in the single Iﬁt1 intron, 6.6 kb 3=
to the promoter (Fig. 3C). To test whether each DSB affected ongoing transcription, we
induced Iﬁt1 expression 2 h prior to nucleofection with gRNAs (Fig. 3F). We then
assessed nascent transcript levels at 24 h postnucleofection using primer sets upstream
(primer set P1) and downstream (primer set P3) of the intronic break site, as well as
spliced Iﬁt1 transcripts (primer set P2) (Fig. 3C). As expected, nascent mRNA levels were
reduced when a DSB was introduced into the Iﬁt1 intron, which disrupts the transcrip-
tional unit (Fig. 3G). Importantly, repression also was observed upon introduction of the
gIﬁt1 3= DSB downstream of the transcriptional unit and its polyadenylation site
(Fig. 3H). As a control for general effects on the interferon response, we found that
transcript levels for Isg15, an IFN--induced gene on chromosome 4, were unaltered
(Fig. 3G and H). Consistent with our data for Irf4, we conclude that a DSB either within
or outside the Iﬁt1 gene represses its ongoing transcriptional activity.
Notably, the Iﬁt1 locus also allowed us to gauge the impact of a DSB on induced
transcription rather than simply ongoing gene expression. For this purpose, we treated
the G1-arrested cells with IFN- at 24 h after nucleofection, the time point of maximal
DSB accumulation (Fig. 3D, E, and I). Analysis of the induced mRNA levels after 4 h of
IFN- treatment revealed a DSB-dependent reduction in Iﬁt1 transcripts, regardless of
whether the DSB was targeted within or downstream of the Iﬁt1 gene body (Fig. 3J and
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K). Thus, establishment of repression at an endogenous DSB site is not dependent on
preexisting transcriptional activity. Importantly, our data also demonstrate that DSBs in
G1 phase cells both repress ongoing transcription and block induced expression of a
neighboring gene, even in the presence of a potent activating signal.
One recent study implicated the c-Abl kinase in facilitating transcription at DSB sites
(35). To ensure that c-Abl inhibition by imatinib is not the sole underlying mechanism
FIG 2 Gene body or 5= DSBs attenuate expression of the endogenous Irf4 gene. (A) Schematic of the Irf4 locus.
gRNA target sites are denoted by yellow arrows. The qPCR primers used to detect Irf4 transcripts are shown as red
arrows. The distances between gRNA target sites and the Irf4 promoter are indicated. chr13, chromosome 13. (B)
Schematic of the Southern blotting strategy for detecting cleaved alleles at the Irf4 intronic gRNA target site (gIrf4
intron) (top) and Southern blot showing intact and cut Irf4 alleles 24 h after nucleofection of doxycycline-treated,
G1-arrested LigIV/:iCas9 cells with the empty gRNA vector or gIrf4 intron (bottom). (C) RT-qPCR analysis of total
Irf4 transcript levels (primer pairs P1 and P2) and a control gene, Tnks2, at 24 h after nucleofection with a gRNA
targeting Irf4 intron 6 (gIrf4 intron). The transcript levels relative to those in cells nucleofected with an empty gRNA
control vector (gEmpty) are shown. (D) RT-qPCR analysis of nascent transcript levels from samples for which the
results are shown in panel C, performed using the Click-iT nascent RNA capture technology. Cells were pulsed with
5-ethynyl uridine (EU) 1 h prior to harvesting for RNA isolation. (E) Southern blot schematic and Southern blot, as
described in the legend to panel B, for gRNA targeting the region 9.5 kb upstream of the Irf4 promoter (gIrf4 5=).
(F) RT-qPCR analysis of total transcript levels, as described in the legend to panel C, for cells nucleofected with a
gRNA targeting the region 9.5 kb upstream of the Irf4 promoter (gIrf4 5=). (G) RT-qPCR analysis of nascent transcript
levels, as described in the legend to panel D, from samples for which the results are shown in panel F. Data from
panels C and D and from panels F and G represent those from 3 independent experiments (n 3). Error bars show
the SEM. *, P  0.05; **, P 0.01; n.s., not signiﬁcant.
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FIG 3 Persistent DSBs impede ongoing and induced transcription of an endogenous gene. (A) RT-qPCR analysis of total transcript levels of Iﬁt1 (primer pair
P2) in G1-arrested LigIV/ cells at the indicated time points after treatment with 100 U/ml IFN-. The transcript levels relative to the levels in untreated cells
(0-h time point) are shown. (B) Immunoblot (IB) analysis of -H2AX levels in G1-arrested LigIV/ cells that were untreated or treated with 100 U/ml IFN- or
5 g/ml of the DNA-damaging agent bleomycin (Bleocin) for 24 h. GAPDH expression is shown as a protein loading control. (C) Schematic of the Iﬁt1 locus.
gRNA target sites are denoted by yellow arrows, and the qPCR primers used to detect Iﬁt1 transcripts are shown as red arrows. The distances between gRNA
target sites and the Iﬁt1 promoter are indicated. (D) Schematic of the Southern blotting strategy for detecting cleaved alleles at the Iﬁt1 intronic gRNA target
site (gIﬁt1 intron) (top) and Southern blots showing intact and cut Iﬁt1 alleles at 24 h (left) or 28 h (right) after nucleofection of G1-arrested, LigIV/:iCas9 cells
with an empty gRNA vector (gEmpty) or the gIﬁt1 intron (bottom). Cells were treated with 100 U/ml IFN-, as described in the work ﬂow presented in panel
F (left) or as described in the work ﬂow presented in panel I (right). (E) Schematic of the Southern blotting strategy for detecting cleaved alleles at the Iﬁt1 3=
(Continued on next page)
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for transcriptional repression in response to DSBs at an adjacent gene, we arrested
LigIV/:iCas9 cells in G1 using the CDK4/6 inhibitor palbociclib, which spares c-Abl
activity (59). Both gene body and downstream breaks blocked Iﬁt1 induction in
palbociclib-treated cells, indicating that DSB-dependent repression of local gene tran-
scription is independent of Abl kinase inhibition via imatinib (Fig. 3L and M).
Chromatin accessibility near persistent DSBs. A potential mechanism by which
DSBs mediate transcriptional repression could be a break-induced loss of chromatin
accessibility at nearby regulatory elements. In this regard, prior studies generally have
concluded that DSBs enhance accessibility at DNA ends but lead to compaction of
ﬂanking chromatin (18, 36–38). However, the impact of a single DSB on chromatin
accessibility at proximal regulatory elements remains unknown. The well-deﬁned reg-
ulatory architecture of Iﬁt1 afforded an ideal opportunity to test DSB-accessibility
relationships.
For this purpose, we examined chromatin accessibility following the introduction of
targeted Iﬁt1 DSBs via the assay for transposase-accessible chromatin using sequencing
(ATAC-seq). Cells harboring the Iﬁt1 intronic break and treated with IFN-, as outlined
in Fig. 3I, exhibited enhanced accessibility for 500 bp on either side of the DSB site
(Fig. 4A). Notably, the Iﬁt1 promoter remained accessible, despite potent transcriptional
repression (Fig. 4A). Statistical comparison of global ATAC-seq data for control cells
versus those for cells harboring an Iﬁt1 intronic DSB revealed no signiﬁcant changes in
chromatin accessibility genome-wide, with the exception of the break site itself
(Fig. 4B). We conclude that global chromatin accessibility remains remarkably stable in
the presence of a DSB and that the break-induced block in Iﬁt1 transcription is not
driven by occlusion of its promoter.
DSB-dependent transcriptional repression extends to distal genes within the
-H2AX domain. Previous studies have suggested that DSB-dependent transcriptional
repression is limited to genes that are either directly damaged by a break or situated
within a few kilobases of the lesion (18, 20, 21, 39, 40). Since DDR-signaling platforms
in chromatin extend hundreds of kilobases from a break site, we hypothesized that
transcriptional silencing might spread further in G1 cells, perhaps throughout the
-H2AX domain. The efﬁciency of DSB formation in v-Abl-transformed cells, coupled
with unique features of the Iﬁt locus, namely, the proximity of several interferon-
inducible genes, permits us to test more rigorously whether repression spreads beyond
a directly adjacent gene.
Initially, we measured IFN--induced transcription of neighboring genes Iﬁt3b, Iﬁt3,
and Iﬁt2 (Fig. 5A) in cells harboring an intragenic Iﬁt1 break. DSB-mediated repression
extended to all of the inducible Iﬁt genes in this region, albeit to a lesser extent than
Iﬁt1 itself (Fig. 5B). Similarly, a DSB introduced into a second Iﬁt gene, Iﬁt2, blocked
activation of the other IFN--inducible genes in this cluster (Fig. 5C). We conclude that
regional repression is independent of the precise DSB location.
We next sought to determine if repression extended to more distal genes within the
-H2AX domain in response to a DSB. The intronic break in Iﬁt1 produced a -H2AX
FIG 3 Legend (Continued)
gRNA target site (gIﬁt1 3=) (top) and Southern blots showing intact and cut Iﬁt1 alleles, as described in the legend to panel D (bottom). (F) Work ﬂow for the
ongoing transcription experiments whose results are shown in panels G and H. (G) RT-qPCR analysis of nascent transcript levels of Iﬁt1 (primer pairs P1, P2,
and P3) and a control interferon-stimulated gene on a separate chromosome, Isg15, at 24 h after nucleofection with a gRNA targeting the Iﬁt1 intron (gIﬁt1
intron). Cells were treated with 100 U/ml IFN- 2 h prior to nucleofection and pulsed with EU 1 h prior to harvesting for RNA isolation. Nascent transcripts were
isolated with the Click-iT nascent RNA capture technology. Transcript levels are shown relative to the levels in cells nucleofected with an empty gRNA vector.
(H) RT-qPCR analysis of nascent transcript levels of Iﬁt1, as described in the legend to panel G, after nucleofection with a gRNA targeting the region 3 kb
downstream of the Iﬁt1 gene body (gIﬁt1 3=). (I) Work ﬂow for the induced transcription experiments whose results are shown in panels J to M. (J) RT-qPCR
analysis of induced transcript levels of Iﬁt1 (primer pairs P1, P2, and P3) and Isg15 at 28 h after nucleofection with a gRNA targeting the Iﬁt1 intron (gIﬁt1 intron).
Cells were treated with 100 U/ml IFN- for 4 h at 24 h after nucleofection. Transcript levels are shown relative to the levels in cells nucleofected with gEmpty.
(K) RT-qPCR analysis of induced transcript levels of Iﬁt1, as described in the legend to panel J, after nucleofection with gIﬁt1 3=. (L) RT-qPCR analysis of induced
transcript levels of Iﬁt1 and Isg15 in cells arrested in G1 with palbociclib, followed by nucleofection and treatment, as described in the legend to panel J. (M)
RT-qPCR analysis of induced transcript levels of Iﬁt1 and Isg15 in cells arrested in G1 with palbociclib, followed by nucleofection and treatment, as described
in the legend to panel K. Data from panels G, H, and J to M represent those from 3 independent experiments (n 3). Error bars show the SEM. *, P 0.05;
**, P 0.01; ***, P 0.001; n.s., not signiﬁcant. txn, transcription.
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domain that spread for several hundred kilobases on each side, as monitored by
chromatin immunoprecipitation-DNA sequencing (ChIP-seq) (Fig. 5D). Two constitu-
tively expressed genes, Stambpl1 and Kif20b, are located near each end of the region
decorated by -H2AX. Remarkably, we observed a signiﬁcant reduction in the transcript
levels of Kif20b (40%), which is located 275 kb away from the Iﬁt1 DSB (Fig. 5E). The
transcription of Stambpl1, whose promoter lies 455 kb away from the Iﬁt1 DSB, also
was affected signiﬁcantly, albeit to a lesser extent (20%) (Fig. 5E). In contrast, the
expression of two genes positioned on either side of the -H2AX domain, Atad and
Tnks2, remained unchanged (Fig. 5F). Indeed, whole-transcriptome analysis of control
versus Iﬁt1 DSB samples revealed a signiﬁcant DSB-dependent decrease in the expres-
sion of genes lying within the Iﬁt1 -H2AX domain compared to all other genes
(Fig. 5G). Furthermore, breaks at Iﬁt2 elicited similar levels of Stambpl1 and Kif20b
repression (Fig. 5H). Thus, we conclude that DSB-induced transcriptional repression in
an endogenous locus can spread for several hundred kilobases on either side of a break
site throughout the -H2AX domain.
DSB-induced local gene silencing depends on the DNA damage response and
reduced RNAPII activity. To determine whether the spread of gene repression from a
DSB site requires DDR signaling, which generates -H2AX, we treated cells with
FIG 4 DSB-induced changes in chromatin accessibility are limited to the break site itself. (A) UCSC Genome Browser screenshot depicting
the ATAC-seq signal at the Iﬁt1 locus in G1-arrested LigIV/ v-Abl-transformed pre-B cells nucleofected with gEmpty (top track) and the
gIﬁt1 intron (bottom track) and treated with IFN-, as outlined in Fig. 3I. The arrow denotes the gIﬁt1 intron target site. (B) Plot depicting
the log2 fold change of the read counts for each ATAC-seq peak and the mean of the normalized read counts for each peak between cells
nucleofected with gEmpty and cells nucleofected with the gIﬁt1 intron and treated with IFN-, as outlined in Fig. 3I (results are averages
from three biological replicates [n 3]). Each dot represents an individual ATAC-seq peak. Two peaks (indicated in red) are called
signiﬁcantly different by the DESeq2 program (Wald test, P 0.05) and correspond to the peaks on either side of the Iﬁt1 intronic DSB,
as visualized in panel A.
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FIG 5 DSB-dependent transcriptional repression spreads to distal genes within the -H2AX domain. (A) Schematic of the Iﬁt locus.
IFN--inducible genes (ISGs) are shown in black. The gIﬁt1 intron break site and the gIﬁt2 break site are denoted in red and blue,
respectively. The distances from the promoters of each ISG and each DSB site are indicated below. (B) RT-qPCR analysis of induced
transcript levels of Iﬁt locus ISGs in cells nucleofected with the gIﬁt1 intron. Transcript levels are shown relative to the levels in cells
nucleofected with gEmpty and treated with IFN-, as outlined in Fig. 3I. (C) RT-qPCR analysis of induced transcript levels of Iﬁt locus ISGs
in cells nucleofected with gRNA targeting Iﬁt2 exon 3 (gIﬁt2). Transcript levels are shown relative to the levels in cells nucleofected with
gEmpty and treated with IFN-, as described in the legend to panel B. (D) UCSC Genome Browser screenshot depicting the -H2AX
ChIP-seq signal at the Iﬁt locus in LigIV/:iCas9 cells at 24 h after nucleofection with the gIﬁt1 intron. Distal genes lying within the -H2AX
domain are shown in black. The gIﬁt1 intron break site and the gIﬁt2 break site are denoted in red and blue, respectively. The distances
from the promoters of each distal gene and each DSB site are indicated below. (E) RT-qPCR analysis of the total transcript levels of distal
genes Stambpl1 and Kif20b from the experiments whose results are presented in panel B. (F) RT-qPCR analysis of total transcript levels of
Atad and Tnks2 from the experiments whose results are presented in panel B. Atad and Tnks2 are located upstream and downstream of
the Iﬁt1 DSB -H2AX domain, respectively. (G) Violin plot showing the mean log2 fold change of expression between cells nucleofected
with gEmpty and cells nucleofected with the gIﬁt1 intron and treated with IFN-, as outlined in Fig. 3I. Genes located within and outside
the chromosome 19 Iﬁt1 -H2AX peaks (D) are shown in red and gray, respectively. Each dot represents an individual gene. The Wilcoxon
test was used to generate the P value. (H) RT-qPCR analysis of the total transcript levels of distal genes Kif20b and Stambpl1 in cells
nucleofected with gRNA targeting Iﬁt2 exon 3 (gIﬁt2) from the experiments whose results are presented in panel C. The data in panels
B, E, and F represent those from 4 independent experiments (n 4), the data in panels C and H represent those from 3 independent
experiments (n 3), and the data in panel G represent those from 1 biological replicate (n 1). Error bars show the SEM. *, P 0.05; **,
P 0.01; ***, P 0.001; n.s., not signiﬁcant.
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combined ATM (KU55933) and DNA-PKcs (NU7026) inhibitors (DDR inhibitor 1 [DDRi-1]
treatment) or the dimethyl sulfoxide (DMSO) vehicle immediately after gRNA nucleo-
fection. The DDRi-1 treatment did not restore induced Iﬁt1mRNA levels in cells with Iﬁt1
intronic DSBs, possibly because intragenic breaks lead to transcript instability (Fig. 6A).
Consistent with this possibility, when a DSB was targeted outside of the Iﬁt1 gene body
(Iﬁt1 3= DSB), The DDRi-1 treatment partially rescued its transcriptional activation (Fig.
6A). Notably, silencing of the IFN--inducible gene Iﬁt3b and of the constitutive gene
Kif20b also was reversed by DDR inhibition (Fig. 6A). To further conﬁrm that silencing
is dependent on DDR signaling, we employed a second set of ATM (KU60019) and
DNA-PKcs (NU7441) inhibitors (the DDRi-2 treatment), which led to a similar rescue of
transcription at neighboring genes (Fig. 6B). Thus, DDR-dependent repression can
spread for a signiﬁcant distance from a DSB to suppress not only ongoing but also
induced gene transcription in the resultant -H2AX domain.
Prior studies indicated that the levels of elongating or total RNA polymerase II
(RNAPII) are reduced at genes adjacent to DSBs (18, 20, 21). However, it remains unclear
FIG 6 DSB-induced gene silencing depends on the DNA damage response and reduced RNAPII activity. (A) RT-qPCR analysis of
the induced Iﬁt1 transcript in cells nucleofected with the gIﬁt1 intron and of the induced Iﬁt1 and Iﬁt3b transcript and the total
Kif20b transcript in cells nucleofected with gIﬁt1 3=. Cells were nucleofected and then transferred to medium containing DMSO or
an ATM inhibitor (KU55933) and DNA-PKcs inhibitor (NU7026) (the DDRi-1 treatment) and treated with IFN-, as outlined in Fig.
3I. Transcript levels in samples treated with DMSO or the DDRi are shown relative to the levels in cells nucleofected with gEmpty
and treated with DMSO or DDRi, respectively. (B) RT-qPCR analysis, as described in the legend to panel A, for cells treated with
DMSO or an ATM inhibitor (KU60019) and DNA-PKcs inhibitor (NU7441) (the DDRi-2 treatment). (C) Schematic depicting the Iﬁt1
locus, gIﬁt1 3= target site, and Iﬁt1 qPCR primer locations used for the ChIP analysis whose results are presented in panel E. The
distance from the primers to the Iﬁt1 3= gRNA target site is indicated. (D) RT-qPCR analysis of induced transcript levels of Iﬁt1
(primer pair Iﬁt1 P2) and Isg15 at 26 h after nucleofection with gIﬁt1 3=. Cells were treated with 100 U/ml IFN- for 2 h at 24 h after
nucleofection. Transcript levels are shown relative to the levels in cells nucleofected with gEmpty and treated with IFN-. (E) ChIP
analysis of RNAPII CTD S2P occupancy in the Iﬁt1 gene from the experiments whose results are presented in panel D. RNAPII levels
are presented relative to the levels in cells nucleofected with the empty gRNA vector (no DSBs). The relative RNAPII CTD S2P
occupancy at the undamaged Isg15 locus is shown as a control. The data in panel A represent those from 4 independent
experiments (n 4), the data in panel B represent those from three independent experiments (n 3), and the data in panels D
and E represent those from 3 independent experiments (n 3). Error bars show the SEM. *, P 0.05; **, P 0.01; ***, P 0.001;
n.s., not signiﬁcant.
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how RNAPII activity is affected at loci near persistent DSBs in G1 phase cells. We thus
measured the levels of elongating, C-terminal domain Ser2-phosphorylated (CTD S2P)
RNAPII via chromatin immunoprecipitation (ChIP) in response to Iﬁt1 downstream DSBs,
as outlined in Fig. 3I. We chose to focus on DSBs outside the gene body, as they do not
present a physical barrier to RNAPII progression. Because previous reports indicated
that RNAPII levels at Iﬁt1 were maximal at 2 h subsequent to interferon treatment, we
assessed RNAPII CTD S2P occupancy at that time point (41). Indeed, we observed an
20% reduction in transcript levels and a corresponding decrease in elongating RNAPII
levels over the Iﬁt1 gene compared to the levels in undamaged cells (Fig. 6C to E). As
expected, the levels were unchanged at the Isg15 control locus (Fig. 6D and E). Thus, we
conclude that transcriptional repression of DSB-adjacent endogenous genes in G1
phase occurs through a loss of RNAPII activity, corroborating previous ﬁndings in
cycling cells at transcriptional reporter loci (18).
DISCUSSION
A major hurdle for understanding the functional consequences of DDR signaling in
noncycling cells has been a lack of approaches to target DSBs at predetermined sites
in native chromatin. Recently developed cellular systems have used endonucleases that
cleave at a speciﬁc recognition sequence. However, the DSBs are limited to a small
collection of naturally occurring sites that may not be ideal for studying certain aspects
of the damage response. For example, AsiSI and I-PpoI cleave predominantly in
promoter regions or ribosomal DNA repeats, respectively (20, 21, 39, 40). We estab-
lished an experimental system that leverages the ﬂexibility of the CRISPR/Cas9 tech-
nology to generate DSBs in NHEJ-deﬁcient cells arrested in G1 phase. Our approach was
used to create site-speciﬁc DSBs with a high efﬁciency (50 to 90% broken alleles) at
multiple, predetermined genomic sites, enabling us to interrogate transcriptional re-
sponses to persistent DSBs. By targeting breaks to multiple sites in the Iﬁt1 locus, where
transcription is regulated solely by promoter elements, we provide deﬁnitive evidence
that DSBs can repress endogenous gene transcription in G1 phase cells independently
of damage to the gene body itself or its key regulatory elements.
These advances build on prior investigations of DSB-induced silencing, many of
which employed systems that simultaneously generate multiple DSBs within gene
bodies or near genes with ongoing transcriptional activity. Thus, although DSB-mediated
repression of a proximal gene was observed in most cases, it remained unclear whether
preexisting transcriptional activity at or near a break site was required for this functional
outcome. Indeed, the RNA polymerase II-associated factors ENL and NELF-E have been
implicated in DSB-induced repression in cycling cells; however, their recruitment to
DSBs was dependent on active transcription near the break site (22, 42). Leveraging the
inducible nature of Iﬁt genes, we show that DSBs not only repress ongoing gene
expression but also block induced transcription, even when the lesion resides outside
the transcriptional unit. This reduction of the induced Iﬁt1 transcript in response to
adjacent DSBs corresponds with the decreased levels of active RNAPII at Iﬁt1. Although
the precise mechanisms of DSB-mediated gene repression remain an important unre-
solved question, they likely are independent of changes in chromatin accessibility at
key regulatory elements, as revealed by our comparisons of ATAC-seq data for cells
harboring intact or broken Iﬁt alleles.
An important ﬁnding to emerge from our approach is that DSB-mediated repression
is not limited to a neighboring gene. Prior studies had suggested that transcriptional
silencing is restricted to DSB-harboring or -proximal genes, without having a signiﬁcant
impact on other genes within a -H2AX domain (20, 21, 39, 40). In addition, the architectural
complex cohesin was implicated in the protection of more distal -H2AX domain genes
from DSB-mediated repression (43). We found that although transcriptional silencing
required DDR signaling, repression could extend to signiﬁcant distances from a DSB,
even past CTCF-cohesin binding sites, ultimately attenuating expression of both induc-
ible and constitutive genes throughout the resultant -H2AX domain. Although we
cannot rule out the possibility that repression of the Iﬁt genes results from disruption
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of a transcriptional coregulatory mechanism within this locus and not the DSB per se,
the observed repression of the distal genes Kif20b and Stambpl1 suggests bona ﬁde
DSB-dependent long-range gene silencing. Curiously, topoisomerase II (TOP2) localizes
to chromatin loop anchors, where it relieves torsional strain through the formation of
transient, TOP2-linked DNA breaks (44, 45). DSB intermediates in TOP2 cleavage
complexes (TOP2ccs) are thought to be shielded from the DNA surveillance machinery
and do not elicit a DDR (2). Perhaps this cloaking mechanism prevents the regional
transcriptional repression that may be necessary for the efﬁcient and accurate repair of
genotoxic DSBs but not these transient, TOP2-associated breaks.
While it is unclear if -H2AX itself is essential for this mode of transcriptional repression,
the histone modiﬁcation serves as a proxy that highlights the reaches of DDR signaling.
Intriguingly, ATM recruitment may be restricted to only a short stretch of chromatin
near endogenous DSB sites, suggesting that DDR signaling spreads through megabase-
size domains via contacts between the break and more distal sites, rather than through
direct linear propagation (46). Moreover, DSBs appear to boost cis interactions within
-H2AX domains, as revealed using a chromosome conformation capture-based tech-
nique (capture-HiC) (47). In agreement with the results of these studies, we observed a
nonuniform distribution of -H2AX from our Iﬁt1 DSB. This ﬁnding, together with our
transcriptional data, raises the compelling possibility that DSBs enhance the contacts of
surrounding chromatin with ATM loaded near the damaged site to spread DDR
signaling and impose transcriptional silencing at more distal genes. As transcriptionally
active regions are prone to DSBs, it is conceivable that active repression of genes is
important for minimizing the appearance of additional DSBs within a conﬁned region,
thus limiting the risk of genomic rearrangements. Our approach, which generates targeted
endogenous DSBs and a sustained DDR signaling response, should provide a means to
rigorously test such hypotheses in the future. Indeed, the inherent ﬂexibility of this
system should lead to a deeper understanding of factors that facilitate the spread of
DDR signaling to distal sites, as well as its full impact on regional transcription,
chromatin landscapes, and repair.
MATERIALS AND METHODS
Cell culture. LigIV/ v-Abl-transformed pre-B cells were described previously (31, 32). pCW-Cas9
(catalog number 50661; Addgene) was used to generate LigIV/ v-Abl-transformed pre-B cell lines with
a stably integrated, doxycycline-inducible Cas9 (LigIV/:iCas9 cells). For Cas9 induction, LigIV/:iCas9
cells were treated with 6 g/ml doxycycline (Sigma) for 12 h prior to G1 arrest using imatinib (3 M, 106
cells/ml) or palbociclib (5 M, 106 cells/ml). Murine IFN- (100 U/ml; PBL Assay Science) was used to
upregulate IFN--inducible gene (ISG) expression. For DDR inhibitor experiments, cells were treated with
30 M ATM kinase inhibitor KU55933 (Tocris) and 20 M DNA-PKcs inhibitor NU7026 (Selleck) (the
DDRi-1 treatment) or with 2 M ATM kinase inhibitor KU60019 (Selleck) and 4 M DNA-PKcs inhibitor
NU7441 (Selleck) (the DDRi-2 treatment) directly after nucleofection. The duration of the treatments for
each experiment is indicated in the text and ﬁgures.
Plasmids. To generate the pKLV-U6gRNA(BbsI)-UbcThy1.1 gRNA expression vector, pKLV-U6gRNA(BbsI)-
PGKpuro2ABFP (catalog number 50946; Addgene) was digested with BamHI and NotI to remove the
PGKpuro2ABFP cassette and replace it with a Ubc-Thy1.1 cassette. The BbsI site in the Ubc promoter sequence
was destroyed via site-directed mutagenesis. gRNA sequences were cloned into the BbsI gRNA cloning site
as previously described (48).
gRNA design. All gRNA sequences were designed using the MIT CRISPR design tool, with the
exception of gEb, which was previously published (49, 50). The gRNA sequences and oligonucleotide
sequences used for cloning into pKLV-U6gRNA(BbsI)-UbcThy1.1 vector are listed in Table 1.
TABLE 1 gRNA sequences and oligonucleotides for cloning
gRNA name gRNA sequence (5=–3=)
Oligonucleotide sequence for pKLV-BbsI cloning (5=–3=)a
Mouse chromosomeForward Reverse
gEb GAAAGCCAGCCAATGAATGC CACCGAAAGCCAGCCAATGAATGCGT TAAAACGCATTCATTGGCTGGCTTTC 6
gIrf4 intron GGCCAACCCTACACCCTAAA CACCGGCCAACCCTACACCCTAAAGT TAAAACTTTAGGGTGTAGGGTTGGCC 13
gIrf4 5= AGGCTAGGTTACGACTAGAA CACCGGGCTAGGTTACGACTAGAAGT TAAAACTTCTAGTCGTAACCTAGCCC 13
gIﬁt1 intron ATGGCCAGAAATGGACACCG CACCGTGGCCAGAAATGGACACCGGT TAAAACCGGTGTCCATTTCTGGCCAC 19
gIﬁt1 3= CTGTTCTGCTACCTGCCGAG CACCGTGTTCTGCTACCTGCCGAGGT TAAAACCTCGGCAGGTAGCAGAACAC 19
gIﬁt2 CAGACTTCCAGGAGTCGCAT CACCGAGACTTCCAGGAGTCGCATGT TAAAACATGCGACTCCTGGAAGTCTC 19
aUnderlined text denotes sequences appended for cloning into the pKLV-U6gRNA(BbsI)-UbcThy1.1 (pKLV-BbsI) gRNA expression vector.
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Nucleofection. LigIV/:iCas9 cells were treated with doxycycline for 36 h and imatinib for 24 h prior
to nucleofection. For each nucleofection, 20 106 cells were spun down and resuspended in 100 l
Nucleofector solution for human B cells (Lonza) or Chica buffer 1SM (51). Nucleofections were performed
using an Amaxa Nucleofector II device (Lonza), program X-001, according to the manufacturer’s instruc-
tions. Nucleofected cells were transferred directly to preequilibrated recovery medium containing
doxycycline and imatinib at 10 106 cells/ml and incubated for 24 h prior to harvesting for RNA and
genomic DNA. For induced Iﬁt expression experiments, cells were treated with IFN- for 4 h prior to
harvest. IFN- was added to the cell cultures at 2 h before nucleofection and to the recovery medium for
ongoing transcription experiments with DSBs at the Iﬁt1 locus. For DDR inhibitor experiments, cells were
transferred directly to recovery medium containing ATM and DNA-PKcs inhibitors or DMSO.
Southern blotting. Southern blotting of Cas9 DSBs was performed as previously described (50).
Brieﬂy, genomic DNA was isolated from 5 106 cells at the time points indicated above and in the
ﬁgures, and 10 g of gDNA was used for digestion with the restriction enzyme. The restriction digestion
enzymes and oligonucleotides used for ampliﬁcation of the probes from genomic DNA for each Southern
blotting/DSB site are listed in Table 2.
Intracellular staining. Intracellular staining was performed using a BD Cytoﬁx/Cytoperm ﬁxation/
permeabilization solution kit (Thermo Fisher) according to the manufacturer’s instructions. The primary
antibody used was anti-FLAG M2 (catalog number F1804; Sigma).
Flow cytometric analysis. Flow cytometric analyses were performed using a BD FACSCalibur ﬂow
cytometer (BD Biosciences), and the data were analyzed using FlowJo software (FlowJo, LLC). The
antibodies used were phycoerythrin-conjugated anti-rat CD90/mouse CD90.1 (catalog number 205903;
BioLegend) and Alexa Fluor 647-conjugated goat anti-mouse IgG (catalog number A-21235; Invitrogen).
Immunoblot analysis. Whole-cell lysates were prepared using LDS sample buffer (Invitrogen).
Standard immunoblotting techniques were used, as previously described (32). The primary antibodies
used were anti--H2AX (catalog number 05-636; Millipore) and anti-GAPDH (anti-glyceraldehyde-3-
phosphate dehydrogenase; catalog number sc-365062; Santa Cruz).
Total RNA isolation, cDNA synthesis, and RT-qPCR analysis. Total RNA was isolated from 5 106
to 10 106 cells with the TRIzol reagent and DNase treated in solution for 10 min (Qiagen RNase-free
DNase set) to remove any remaining genomic DNA. DNase-treated RNA was then puriﬁed using Qiagen
RNeasy columns. Puriﬁed RNA was quantiﬁed using a NanoDrop 2000 spectrophotometer, and cDNA was
synthesized from 1 g of RNA with random hexamers using SuperScript III reverse transcriptase (Thermo
Fisher). Gene expression was assessed by qPCR using the Sybr green reagent (Sigma) and a Bio-Rad CFX
Connect real-time PCR detection system. A -2-microglobulin transcript was used as a normalization
control for gene expression. The primers used for RT-qPCR analyses are listed in Table 3.
TABLE 2 Southern blot restriction digests and probe sequences
gRNA target site Restriction digestion enzyme(s)
Oligonucleotide sequence (5=–3=)
Forward probe Reverse probe
Eb HindIII CTAGTCCCATCACCTAAGTCCCAG GTCAGCAAATGTTCATAGAGC
Irf4 intron KpnI GGCCTCAGTCTGTGTGGGG GAGAGCCCAGCTAGCATGGG
Irf4 5= BamHI GCATTGTCCTACCTCCAAAGAC CTAGGTTCCTTATGACCATGG
Iﬁt1 intron EcoRI/BamHI GCCATTCATGAATTTCAAGAGAC GAGCCTCAGTGCCTTCTCATAG
Iﬁt1 3= KpnI/EcoRI GCCATTCATGAATTTCAAGAGAC GAGCCTCAGTGCCTTCTCATAG
TABLE 3 RT-qPCR and ChIP-qPCR primer sequences
Primer name
Oligonucleotide sequence (5=–3=)
Forward Reverse
-2-Microglobulin GGTCTTTCTGGTGCTTGTCTCA GTTCGGCTTCCCATTCTCC
Irf4 P1 AAGCAGGACTACAATCGTGAG TCGGAACTTGCCTTTAAACAATG
Irf4 P2 CAGAGACAGAGGAAGCTCATC GTGTTCAGGTAACTCGTAGCC
Iﬁt1 P1 CAAGAGAGCAGAGAGTCAAGG GTGGTAGCTGTTCTCTGGG
Iﬁt1 P2 AGAGTCAAGGCAGGTTTCTG TGTGAAGTGACATCTCAGCTG
Iﬁt1 P3 TCTAGCAGGCAATTCCATCC TCCAAAGGCACAGACATAAGG
Iﬁt3 CCTCTGCTCATCCTAGCCATACA GTGCTCTGTCTGCTTTAAGCTC
Iﬁt3b GAGGTTAAACAGCAAACATAGG CCCTAACCCATTCAGCCACTC
Iﬁt2 CATTAGAAGGCAGAGGAAGAGG GGCATTTTAGCTGTCGCAG
Kif20b AGGAAGTGGAATTCTGCAGG AAAACGTAAGACGGTCTAGGC
Stambpl1 CCGAGATGAAGTGACTGAGAAG CTGTATGGTCAGGCATAGCAG
Atad GACCACGAAGCTACAGCGAT CTTGAGGGCGATTGGTAG
Tnks2 ACCCAAATGCTCGGGATAAT GGCTCAGCTCCATGCTGTAA
Isg15 GCAGACTCCTTAATTCCAGGG TTCAGTTCTGACACCGTCATG
Iﬁt1 ChIP P1 GGCATCTTCCTTCCATTACTTG GACCACAGAAAGAGCATCAGTG
Isg15 ChIP CCACAGCAACATCTATGAGGTC ACTGGTCTTCGTGGACTTGTTC
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Nascent RNA isolation. Nascent RNA was isolated using a Click-iT nascent RNA capture kit (Thermo
Fisher) following the manufacturer’s instructions. Brieﬂy, cells were pulsed with 0.5 mM 5-ethynyl uridine
(EU) for 1 h, and total RNA was harvested using the TRIzol reagent. One microgram of total RNA was used
for the biotinylation reaction, and 300 ng of biotinylated RNA was captured on streptavidin-coated
magnetic beads. cDNA was synthesized using captured, bead-bound RNA as a template with a Super-
Script VILO cDNA synthesis kit (Thermo Fisher). qPCR analysis of cDNA from nascent transcripts was
carried out as described above for total RNA.
Statistical analyses. Graphs for RT-qPCR and ChIP-qPCR data were generated and statistical analyses
were performed using Prism (version 7) software (GraphPad). The transcript levels for samples nucleo-
fected with a targeting gRNA vector were normalized to the transcript levels for the corresponding
samples nucleofected with an empty gRNA control vector (gEmpty), and a one-sample t test was
performed with a hypothetical mean set to 1. For each ChIP sample, the percentage of the input signal
obtained using qPCR was determined. Data are expressed as relative occupancy (percent input relative
to that for the gEmpty [no DSB] RNAPII CTD S2P ChIP sample), and a one-sample t test was performed
with a hypothetical mean set to 1. P values below 0.05 were considered statistically signiﬁcant.
ChIP-qPCR. ChIP assays were done as described previously, with the following modiﬁcations (52).
Brieﬂy, 30 l protein A Dynabeads (Thermo Fisher) per immunoprecipitation (IP) was preincubated with
3 g RNA polymerase II CTD repeat (phospho-S2) antibody (catalog number ab5095; Abcam) or 3 g
normal rabbit IgG antibody (catalog number 12-370; Millipore ) overnight at 4°C. A total of 10 106 cells
per IP were ﬁxed using 1% formaldehyde at room temperature for 10 min, and then the reaction was
quenched with 0.125 M glycine. Isolated nuclei were lysed and sonicated to a 200- to 500-bp average
DNA fragment size using a Covaris M220 focused ultrasonicator (duration, 30 min; peak incident
power [PIP], 75 W; duty factor, 10%; cycles per burst, 200 cycles; temperature, 6°C). Cleared lysates
were incubated with antibody-Dynabeads overnight and then washed and eluted as previously
described (52). Eluted DNA was analyzed by qPCR using the Sybr green reagent (Sigma) and a
Bio-Rad CFX Connect real-time PCR detection system. The primers used for ChIP-qPCR analyses are
listed in Table 3. Data represent the averages from three biological replicates.
ChIP-seq. ChIP assays were done as described previously (52). Brieﬂy, 50 l protein G Dynabeads
(Thermo Fisher) per IP was preincubated with 2 g -H2AX antibody (catalog number 05-636; Millipore)
overnight at 4°C. A total of 3 106 cells per IP were ﬁxed using 1% formaldehyde at room temperature
for 10 min, and then the reaction was quenched with 0.125 M glycine. Isolated nuclei were lysed and
sonicated to a 200- to 500-bp average DNA fragment size using a Diagenode Bioruptor Pico sonication
device (60 cycles; 30 s on and 30 s off). Cleared lysates were incubated with antibody-Dynabeads
overnight and then washed and eluted as previously described (52).
ATAC-seq. Fifty thousand cells per sample were counted, collected, and then washed once in
cold phosphate-buffered saline. The cells were then spun down and resuspended in ATAC lysis
buffer (10 mM Tris-HCl [pH 7.4], 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-630) to isolate the nuclei.
Samples prepared as described above were puriﬁed using MinElute spin columns (Qiagen). Nextera
index adapters (i7 and i5) were used to amplify transposed DNA fragments per the manufacturer’s
protocol (Illumina).
RNA-seq. Total RNA was isolated from LigIV/:iCas9 cells nucleofected with the gIﬁt1 intron or
gEmpty and treated with IFN- as outlined in Fig. 3I and as described above. rRNA was depleted
using a Ribo-Zero rRNA removal kit (Illumina). Transcriptome sequencing (RNA-seq) libraries were
prepared as previously described and sequenced using an Illumina HiSeq 2500 1 50 system (53).
Data processing. ChIP-seq, ATAC-seq, and RNA-seq libraries were prepared as previously described
and sequenced using an Illumina HiSeq 2500 1 50 system (ChIP) or a HiSeq 3000 2 150 system
(ATAC) (53). The demultiplexed libraries were aligned using the NovaAlign tool, processed for normal-
ization of the number of reads per kilobase per million (RPKM) using DeepTool’s BamCoverage tool, and
visualized on the UCSC Genome Browser (54, 55). Peaks were called using the Bowtie2 program (56). For
ATAC analysis, the peaks were concatenated and merged using the BEDtools program, and then the
reads were counted using DeepTool’s multiBamSummary tool (57). Statistically signiﬁcant ATAC regions
were determined using the DEseq2 program (58). For RNA-seq analysis, genes overlapping -H2AX peaks
were determined using BEDtools. DeepTool’s BamCoverage tool was used to determined RPKM-
normalized expression within or outside -H2AX peaks. The R package gpubR was used to statistically
analyze and visualize the relative fold changes between sample groups.
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